When a healthcare provider orders a genetic or genomic test for a patient, the patient’s sample (blood, saliva, or tissue) is sent to a genetic testing laboratory, and then a report comes back indicating the presence or absence of genetic variants in the patient...
CGI’s co-founder and CEO, Dr. Julie Eggington, was a winner of a 2019 Sego Award in Innovation in Technology as a leader in Utah’s business community, a unique accomplishment for the leader of a nonprofit organization. She was recently interviewed by Salt Lake City’s...
“Aligning Genetic and Genomic Test Reimbursement With Value of Tests” is an invited article just published in Clinical Laboratory News of the American Association for Clinical Chemistry, authored by CGI’s Drs. Eggington and Garlapow. They summarize issues with...
CGI’s co-founder, Dr. Julie Eggington, and CGI’s ELEVATEGENETICS Standards Committee member, Dr. John Pfeifer, were interviewed by the American Society of Hematology for their article “Demystifying DNA Variant Reporting”, published on December 1, 2020. Dr. Pfeifer...
CGI presented its work on how pathogenic variant classifications are not always well-supported by evidence. Working together with genetic counselors from Rocky Mountain Cancer Centers and Texas Oncology, CGI collected de-identified patient reports and examined the...
Recent Comments